Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific KNG1 BDK, BK, KNG ENSG00000113889 Kininogen 1 3 186717276-186743954 Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001616, HPA001645, CAB009809 Supported Group enriched 946 kidney: 518.0;liver: 1860.7 rectum: 1.2 UMOD ENSG00000169344 Uromodulin 16 20333052-20356301 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009446, HPA043420, HPA054721 Supported Tissue enriched 718 kidney: 2377.1 cerebral cortex: 3.3 TMEM174 FLJ31268, MGC13034 ENSG00000164325 Transmembrane protein 174 5 73173195-73175143 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA037975 Supported Tissue enriched 685 kidney: 158.0 thyroid gland: 0.2 UGT1A9 HLUGP4, LUGP4, UGT1AI ENSG00000241119 UDP glucuronosyltransferase 1 family, polypeptide A9 2 233671853-233773300 Cancer-related genes, Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 586 kidney: 461.7;liver: 93.2 cerebral cortex: 0.4 ACSM2A A-923A4.1, ACSM2, MGC150530 ENSG00000183747 Acyl-CoA synthetase medium-chain family member 2A 16 20451461-20487667 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA057699 Supported Group enriched 578 kidney: 284.3;liver: 185.7 cerebral cortex: 0.4 SLC12A1 NKCC2 ENSG00000074803 Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 15 48191664-48304078 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014967, HPA018107 Supported Tissue enriched 456 kidney: 773.2 testis: 1.6 SLC22A8 OAT3 ENSG00000149452 Solute carrier family 22 (organic anion transporter), member 8 11 62989154-63015839 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044174 Supported Tissue enriched 391 kidney: 337.6 cerebral cortex: 0.8 HAO2 GIG16, HAOX2 ENSG00000116882 Hydroxyacid oxidase 2 (long chain) 1 119368779-119394130 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 266 kidney: 314.9;liver: 219.3 breast: 1.0 BHMT BHMT1 ENSG00000145692 Betaine--homocysteine S-methyltransferase 5 79111779-79132290 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038285, HPA058310 Supported Supported Cytosol Group enriched 216 kidney: 783.3;liver: 562.6 urinary bladder: 3.1 SLC22A12 OAT4L, RST, URAT1 ENSG00000197891 Solute carrier family 22 (organic anion/urate transporter), member 12 11 64590641-64602353 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024575 Supported Tissue enriched 195 kidney: 104.6 adipose tissue: 0.5 CYP4A11 CYP4A2, CYP4AII ENSG00000187048 Cytochrome P450, family 4, subfamily A, polypeptide 11 1 46929177-46941484 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 175 kidney: 230.7;liver: 447.9 epididymis: 1.9 SLC34A1 NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2 ENSG00000131183 Solute carrier family 34 (type II sodium/phosphate cotransporter), member 1 5 177379235-177398848 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA051255 Approved Tissue enriched 164 kidney: 161.0 liver: 0.9 SLC22A11 OAT4 ENSG00000168065 Solute carrier family 22 (organic anion/urate transporter), member 11 11 64555626-64572875 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026076 Approved Group enriched 134 epididymis: 10.0;kidney: 25.9;placenta: 44.5 seminal vesicle: 0.2 KCNJ1 Kir1.1, ROMK1 ENSG00000151704 Potassium channel, inwardly rectifying subfamily J, member 1 11 128836315-128867373 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level HPA026962 Supported Tissue enriched 118 kidney: 209.0 epididymis: 1.7 SLC12A3 NCCT ENSG00000070915 Solute carrier family 12 (sodium/chloride transporter), member 3 16 56865207-56915850 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028748 Supported Tissue enriched 107 kidney: 109.3 lymph node: 1.0 SLC7A13 AGT-1, XAT2 ENSG00000164893 Solute carrier family 7 (anionic amino acid transporter), member 13 8 86214052-86321146 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 102 kidney: 42.6 testis: 0.4 PRODH2 HSPOX1 ENSG00000250799 Proline dehydrogenase (oxidase) 2 19 35799988-35813299 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA051287 Approved Supported Nucleoplasm
Cytosol Group enriched 94 kidney: 132.6;liver: 45.0 testis: 0.9 AQP2 ENSG00000167580 Aquaporin 2 (collecting duct) 12 49950741-49958881 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA046834 Supported Group enriched 93 kidney: 432.9;seminal vesicle: 299.3 prostate: 3.9 ACSM2B ACSM2, HXMA, HYST1046 ENSG00000066813 Acyl-CoA synthetase medium-chain family member 2B 16 20536226-20576427 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA057699 Supported Group enriched 85 kidney: 423.8;liver: 261.6 thyroid gland: 4.0 HPD 4-HPPD, 4HPPD, GLOD3, PPD ENSG00000158104 4-hydroxyphenylpyruvate dioxygenase 12 121839527-121863596 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038321, HPA038322 Supported Uncertain Nuclear speckles Group enriched 85 kidney: 526.3;liver: 1290.5 testis: 10.6 SLC22A2 OCT2 ENSG00000112499 Solute carrier family 22 (organic cation transporter), member 2 6 160171061-160277638 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008567, CAB068236, CAB068237 Supported Tissue enriched 83 kidney: 149.2 seminal vesicle: 1.7 SLC6A18 FLJ31236, Xtrp2 ENSG00000164363 Solute carrier family 6 (neutral amino acid transporter), member 18 5 1225355-1246189 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA011885 Supported Tissue enriched 83 kidney: 8.2 epididymis: 0.0 NPHS2 PDCN, SRN1 ENSG00000116218 Nephrosis 2, idiopathic, steroid-resistant (podocin) 1 179550539-179575952 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037267, HPA049486 Supported Tissue enriched 79 kidney: 92.9 testis: 1.1 SLC22A6 OAT1, PAHT, ROAT1 ENSG00000197901 Solute carrier family 22 (organic anion transporter), member 6 11 62936385-62984983 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 63 kidney: 199.6 cerebral cortex: 3.1 SLC22A7 NLT, OAT2 ENSG00000137204 Solute carrier family 22 (organic anion transporter), member 7 6 43295694-43305538 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030220 Approved Group enriched 63 kidney: 50.1;liver: 167.4 testis: 1.7 TMEM207 ENSG00000198398 Transmembrane protein 207 3 190428655-190449876 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA014332 Uncertain Tissue enriched 62 kidney: 18.5 testis: 0.2 POU3F3 BRN1, OTF8 ENSG00000198914 POU class 3 homeobox 3 2 104855511-104860471 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA052792, HPA056039, HPA067151 Supported Supported Nucleus Group enriched 51 cerebral cortex: 36.6;epididymis: 34.9;kidney: 28.3;seminal vesicle: 17.2 skin: 0.5 SLC22A24 MGC34821, NET46 ENSG00000197658 Solute carrier family 22, member 24 11 63079940-63144221 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045015 Uncertain Tissue enriched 46 kidney: 4.6 adipose tissue: 0.0 SLC22A13 OAT10, OCTL1, OCTL3, ORCTL3 ENSG00000172940 Solute carrier family 22 (organic anion/urate transporter), member 13 3 38265812-38278315 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA035603, HPA035962 Supported Tissue enriched 39 kidney: 10.6 testis: 0.2 DAO DAMOX ENSG00000110887 D-amino-acid oxidase 12 108858932-108901043 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038653, HPA038654 Supported Group enriched 36 kidney: 89.2;liver: 73.8 rectum: 2.2 MCCD1 ENSG00000204511 Mitochondrial coiled-coil domain 1 6 31528717-31530232 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046948 Uncertain Tissue enriched 36 kidney: 3.5 epididymis: 0.0 DUSP9 MKP-4, MKP4 ENSG00000130829 Dual specificity phosphatase 9 X 153642492-153651326 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003336 Supported Approved Endoplasmic reticulum Group enriched 35 kidney: 28.9;placenta: 102.9 testis: 1.8 AGXT2 AGT2 ENSG00000113492 Alanine--glyoxylate aminotransferase 2 5 34998101-35048135 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037382 Approved Group enriched 32 kidney: 196.2;liver: 59.1 small intestine: 4.0 SLC10A2 ASBT, ISBT ENSG00000125255 Solute carrier family 10 (sodium/bile acid cotransporter), member 2 13 103043998-103066846 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA004795 Approved Group enriched 32 duodenum: 21.6;kidney: 15.3;small intestine: 52.2 gallbladder: 0.9 DIO1 TXDI1 ENSG00000211452 Deiodinase, iodothyronine, type I 1 53891239-53911086 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Group enriched 30 kidney: 146.4;liver: 94.7;thyroid gland: 433.9 fallopian tube: 7.5 MIOX ALDRL6 ENSG00000100253 Myo-inositol oxygenase 22 50486784-50490648 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039451, HPA039562 Supported Tissue enriched 30 kidney: 818.9 thyroid gland: 26.8 FXYD4 CHIF ENSG00000150201 FXYD domain containing ion transport regulator 4 10 43371642-43376335 Predicted membrane proteins Evidence at protein level Evidence at protein level No evidence HPA058421 Supported Tissue enriched 27 kidney: 126.8 stomach: 4.7 SLC28A1 CNT1 ENSG00000156222 Solute carrier family 28 (concentrative nucleoside transporter), member 1 15 84884654-84945796 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019551 Supported Group enriched 26 duodenum: 39.0;kidney: 49.1;liver: 35.4;small intestine: 54.7 placenta: 1.6 SLC36A2 PAT2, TRAMD1, tramdorin ENSG00000186335 Solute carrier family 36 (proton/amino acid symporter), member 2 5 151314978-151347590 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044002, HPA062229 Supported Group enriched 26 kidney: 67.2;skeletal muscle: 28.1 testis: 1.8 SLC5A10 SGLT5 ENSG00000154025 Solute carrier family 5 (sodium/sugar cotransporter), member 10 17 18950345-19022595 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052014 Uncertain Tissue enriched 25 kidney: 43.7 bone marrow: 1.7 ALDH8A1 ALDH12 ENSG00000118514 Aldehyde dehydrogenase 8 family, member A1 6 134917390-134950122 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026292, HPA055414 Supported Approved Centrosome Group enriched 24 kidney: 73.9;liver: 127.6 epididymis: 4.2 UPB1 BUP1 ENSG00000100024 Ureidopropionase, beta 22 24494107-24528390 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000728 Supported Group enriched 24 kidney: 50.8;liver: 161.3 testis: 4.4 ALDOB ENSG00000136872 Aldolase B, fructose-bisphosphate 9 101420578-101435823 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002198, CAB020827 Supported Group enriched 23 duodenum: 3808.7;kidney: 6531.8;liver: 5081.5;small intestine: 5731.3 gallbladder: 232.6 CLEC18C MGC34761 ENSG00000157335 C-type lectin domain family 18, member C 16 70173322-70187361 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA048976 Uncertain Group enriched 23 kidney: 12.2;testis: 3.6 duodenum: 0.3 CUBN gp280, IFCR, MGA1 ENSG00000107611 Cubilin (intrinsic factor-cobalamin receptor) 10 16823964-17129831 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 22 kidney: 152.5;small intestine: 55.3 thyroid gland: 4.7 DPYS DHPase ENSG00000147647 Dihydropyrimidinase 8 104330324-104467053 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024785 Supported Group enriched 22 kidney: 199.0;liver: 245.6 gallbladder: 10.2 ERICH4 C19orf69, LOC100170765 ENSG00000204978 Glutamate-rich 4 19 41443158-41444765 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA042632, HPA048484 Uncertain Approved Nucleoplasm
Cytosol Group enriched 22 duodenum: 44.1;kidney: 16.2;small intestine: 43.8 lung: 1.6 PFN3 ENSG00000196570 Profilin 3 5 177400107-177400636 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Group enriched 22 kidney: 1.1;testis: 3.2 epididymis: 0.0 SLC6A19 ENSG00000174358 Solute carrier family 6 (neutral amino acid transporter), member 19 5 1201595-1225117 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037415, HPA043207 Supported Group enriched 21 duodenum: 143.3;kidney: 91.3;small intestine: 160.0 rectum: 6.3 TMEM52B C12orf59, FLJ31166 ENSG00000165685 Transmembrane protein 52B 12 10170542-10191801 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA058096 Supported Approved Focal adhesion sites Tissue enriched 21 kidney: 182.6 placenta: 8.7 CTXN3 ENSG00000205279 Cortexin 3 5 127649044-127658630 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence Tissue enriched 18 kidney: 77.9 skeletal muscle: 4.3 FTCD ENSG00000160282 Formimidoyltransferase cyclodeaminase 21 46136262-46155567 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020073, HPA030928, HPA030929, HPA036114 Supported Approved Plasma membrane
Cytosol Group enriched 18 kidney: 100.1;liver: 184.7 testis: 7.7 NAT8 ATase2, GLA, Hcml1, TSC501 ENSG00000144035 N-acetyltransferase 8 (GCN5-related, putative) 2 73640832-73642393 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB045990, HPA074519 Uncertain Approved Endoplasmic reticulum Tissue enriched 18 kidney: 885.6 liver: 49.4 RNF212B C14orf164 ENSG00000215277 Ring finger protein 212B 14 23185316-23273477 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA053574 Uncertain Group enriched 17 kidney: 26.6;testis: 10.2 epididymis: 1.0 SLC4A9 AE4 ENSG00000113073 Solute carrier family 4, sodium bicarbonate cotransporter, member 9 5 140360202-140375143 Plasma proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051307 Uncertain Tissue enriched 17 kidney: 12.1 testis: 0.6 SOST VBCH ENSG00000167941 Sclerostin 17 43753731-43758788 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB025660 Approved Tissue enriched 16 kidney: 10.3 lung: 0.6 TMEM27 NX17 ENSG00000147003 Transmembrane protein 27 X 15627318-15665031 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048543 Approved Approved Endoplasmic reticulum
Vesicles Tissue enriched 16 kidney: 418.5 parathyroid gland: 26.1 ATP6V0D2 ATP6D2, FLJ38708, VMA6 ENSG00000147614 ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 8 85987323-86154228 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA055327, HPA058496 Supported Approved Vesicles Tissue enriched 15 kidney: 59.1 lung: 3.8 CYP4A22 ENSG00000162365 Cytochrome P450, family 4, subfamily A, polypeptide 22 1 47137435-47149741 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 15 kidney: 33.4;liver: 109.0 epididymis: 4.6 CALB1 CALB ENSG00000104327 Calbindin 1, 28kDa 8 90058608-90095475 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002138, HPA023099, HPA056734 Supported Supported Vesicles Tissue enriched 14 kidney: 337.3 cerebral cortex: 24.8 FAM151A C1orf179, MGC27169 ENSG00000162391 Family with sequence similarity 151, member A 1 54609182-54623556 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA016840 Approved Uncertain Nucleoplasm Group enriched 14 kidney: 175.6;small intestine: 68.0 liver: 8.5 SLC34A3 FLJ38680, NPTIIc ENSG00000198569 Solute carrier family 34 (type II sodium/phosphate cotransporter), member 3 9 137230757-137236554 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023776 Supported Group enriched 14 kidney: 11.8;small intestine: 9.2 testis: 0.7 SLC6A13 GAT2 ENSG00000010379 Solute carrier family 6 (neurotransmitter transporter), member 13 12 220621-262873 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036449, HPA052726 Approved Approved Mitochondria Tissue enriched 14 kidney: 152.9 fallopian tube: 11.2 UGT2B7 UGT2B9 ENSG00000171234 UDP glucuronosyltransferase 2 family, polypeptide B7 4 69051363-69112987 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045108 Uncertain Group enriched 14 kidney: 1315.4;liver: 823.8 fallopian tube: 79.1 UPP2 UDRPASE2, UP2, UPASE2 ENSG00000007001 Uridine phosphorylase 2 2 157876702-158136154 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035225, HPA035226 Approved Nucleus
Vesicles
Mitochondria Group enriched 14 kidney: 51.8;liver: 14.4 cerebral cortex: 2.4 CH507-152C13.3 ENSG00000276076 Alpha-crystallin A chain 21 6560714-6564489 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level HPA037737 Approved Nucleoplasm
Cytosol Tissue enriched 13 kidney: 57.1 liver: 4.3 GLYATL1 FLJ34646, MGC15397 ENSG00000166840 Glycine-N-acyltransferase-like 1 11 58905398-59043527 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039501 Supported Uncertain Golgi apparatus
Cytosol Group enriched 13 kidney: 144.3;liver: 295.8 prostate: 16.3 OR2T10 ENSG00000184022 Olfactory receptor, family 2, subfamily T, member 10 1 248592830-248593768 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052019 Uncertain Tissue enriched 13 kidney: 7.1 prostate: 0.5 PROZ PZ ENSG00000126231 Protein Z, vitamin K-dependent plasma glycoprotein 13 113158654-113172383 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052006 Approved Group enriched 13 kidney: 14.5;liver: 27.4 testis: 1.6 RDH8 PRRDH, SDR28C2 ENSG00000080511 Retinol dehydrogenase 8 (all-trans) 19 10013249-10022279 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Group enriched 13 kidney: 1.9;testis: 1.9 appendix: 0.1 XPNPEP2 ENSG00000122121 X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound X 129738974-129769538 Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA000339, CAB025136, CAB025269 Supported Approved Golgi apparatus Group enriched 13 duodenum: 131.6;kidney: 174.6;small intestine: 236.2 liver: 14.3 CLDN19 ENSG00000164007 Claudin 19 1 42733093-42740254 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 12 kidney: 19.6;placenta: 14.4 breast: 1.4 NOX4 KOX, KOX-1 ENSG00000086991 NADPH oxidase 4 11 89324356-89498187 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015475 Uncertain Approved Nucleus Tissue enriched 12 kidney: 133.6 parathyroid gland: 10.7 SLC39A5 ENSG00000139540 Solute carrier family 39 (zinc transporter), member 5 12 56230049-56237846 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018423 Approved Nucleoplasm
Vesicles
Cytosol Group enriched 12 colon: 74.5;duodenum: 247.0;kidney: 114.6;liver: 85.7;pancreas: 53.1;rectum: 49.7;small intestine: 245.4 gallbladder: 10.0 ATP6V1G3 ATP6G3, Vma10 ENSG00000151418 ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 1 198523222-198540945 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA028701 Supported Tissue enriched 11 kidney: 21.1 epididymis: 1.9 CLDN14 DFNB29 ENSG00000159261 Claudin 14 21 36460621-36576569 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 11 kidney: 3.6;liver: 9.6 gallbladder: 0.6 DMGDH ENSG00000132837 Dimethylglycine dehydrogenase 5 78997606-79236038 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036441, HPA036442, HPA077849 Supported Uncertain Mitochondria Group enriched 11 kidney: 177.8;liver: 146.1 epididymis: 14.7 KHK ENSG00000138030 Ketohexokinase (fructokinase) 2 27086747-27100772 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007040 Supported Approved Cytosol Group enriched 11 duodenum: 116.2;kidney: 111.0;liver: 97.3;small intestine: 135.8 cerebral cortex: 10.1 ABCC2 CMOAT, cMRP, DJS, MRP2 ENSG00000023839 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 10 99782732-99852192 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004860, CAB037271 Approved Group enriched 10 duodenum: 44.7;gallbladder: 42.8;kidney: 20.8;liver: 67.6;small intestine: 50.5 breast: 4.3 ACMSD ENSG00000153086 Aminocarboxymuconate semialdehyde decarboxylase 2 134838547-134902034 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010533, HPA011179 Supported Uncertain Cytosol Group enriched 10 kidney: 136.5;liver: 80.0 gallbladder: 10.9 ATP6V1B1 ATP6B1, RTA1B, VATB, Vma2, VPP3 ENSG00000116039 ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 2 70935882-70965406 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009523, HPA031847 Supported Approved Nucleus
Nuclear membrane Group enriched 10 breast: 16.0;cervix, uterine: 47.5;fallopian tube: 20.8;kidney: 64.5;placenta: 27.6;salivary gland: 67.0 skin: 4.2 CLEC18B ENSG00000140839 C-type lectin domain family 18, member B 16 74408270-74421953 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA048976 Uncertain Group enriched 10 kidney: 30.8;testis: 8.2 cerebral cortex: 2.0 GLYAT ACGNAT, GAT ENSG00000149124 Glycine-N-acyltransferase 11 58640426-58731974 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040251, HPA044094 Supported Group enriched 10 kidney: 579.6;liver: 353.8 adipose tissue: 47.4 PLA2G12B PLA2G13 ENSG00000138308 Phospholipase A2, group XIIB 10 72935170-72954778 Plasma proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA057745, HPA059562 Approved Approved Vesicles Group enriched 10 duodenum: 36.2;kidney: 18.9;liver: 49.8;small intestine: 46.9 lung: 3.9 SLC7A9 CSNU3 ENSG00000021488 Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 19 32830509-32869766 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042591 Supported Group enriched 10 duodenum: 81.2;kidney: 69.6;small intestine: 125.7 liver: 8.9 AQP6 AQP2L ENSG00000086159 Aquaporin 6, kidney specific 12 49967194-49977139 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA015278 Supported Tissue enriched 9 kidney: 20.8 cerebral cortex: 2.3 ATP6V0A4 a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2 ENSG00000105929 ATPase, H+ transporting, lysosomal V0 subunit a4 7 138706295-138799560 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018029, HPA064555 Supported Approved Cytosol Group enriched 9 kidney: 69.1;salivary gland: 31.8 breast: 5.5 CCDC150 FLJ39660 ENSG00000144395 Coiled-coil domain containing 150 2 196639554-196763490 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043968, HPA048104 Uncertain Approved Nucleoplasm Group enriched 9 kidney: 2.6;testis: 8.8 liver: 0.6 CDHR5 FLJ20219, MU-PCDH, MUCDHL, MUPCDH ENSG00000099834 Cadherin-related family member 5 11 616565-626078 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009081, HPA009173, CAB025004 Supported Group enriched 9 colon: 42.5;duodenum: 85.2;kidney: 23.4;liver: 20.6;rectum: 55.1;small intestine: 65.8 gallbladder: 5.3 CLCNKA hClC-Ka ENSG00000186510 Chloride channel, voltage-sensitive Ka 1 16018875-16034050 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA057717 Approved Group enriched 9 kidney: 63.9;parathyroid gland: 39.6 thyroid gland: 5.5 HRSP12 P14.5, PSP, UK114 ENSG00000132541 Heat-responsive protein 12 8 98102344-98117241 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA022856, HPA023489 Supported Group enriched 9 kidney: 451.5;liver: 696.6 cerebral cortex: 62.5 NXPH2 NPH2 ENSG00000144227 Neurexophilin 2 2 138670772-138780348 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA034759 Approved Group enriched 9 cerebral cortex: 5.7;kidney: 5.0;ovary: 13.9 endometrium: 0.9 SLC17A3 NPT4 ENSG00000124564 Solute carrier family 17 (organic anion transporter), member 3 6 25833066-25882286 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016569 Uncertain Tissue enriched 9 kidney: 167.2 liver: 18.5 SLC5A2 SGLT2 ENSG00000140675 Solute carrier family 5 (sodium/glucose cotransporter), member 2 16 31483002-31490860 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041603 Supported Tissue enriched 9 kidney: 25.3 testis: 2.8 TMEM213 ENSG00000214128 Transmembrane protein 213 7 138797952-138838101 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level No evidence HPA054059 Approved Group enriched 9 kidney: 80.1;salivary gland: 22.8 breast: 5.8 C5orf67 ENSG00000225940 Chromosome 5 open reading frame 67 5 56511567-56606232 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence Group enriched 8 epididymis: 19.4;kidney: 9.3 thyroid gland: 1.8 CDH16 ENSG00000166589 Cadherin 16, KSP-cadherin 16 66908122-66918984 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB013526, HPA036260 Supported Group enriched 8 kidney: 230.2;thyroid gland: 57.6 fallopian tube: 16.9 CLRN3 MGC32871, TMEM12, USH3AL1 ENSG00000180745 Clarin 3 10 127877841-127892947 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014482 Approved Group enriched 8 colon: 71.2;duodenum: 75.4;gallbladder: 23.7;kidney: 43.9;liver: 40.2;rectum: 77.5;small intestine: 99.5 appendix: 7.5 FMO1 ENSG00000010932 Flavin containing monooxygenase 1 1 171248471-171285978 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA023680 Uncertain Tissue enriched 8 kidney: 218.3 small intestine: 25.7 HOXC10 HOX3I ENSG00000180818 Homeobox C10 12 53985065-53990279 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053919 Uncertain Supported Nuclear bodies Group enriched 8 kidney: 18.8;skeletal muscle: 40.3;skin: 8.4 breast: 2.6 LRRC19 FLJ21302 ENSG00000184434 Leucine rich repeat containing 19 9 26993136-27005693 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Group enriched 8 colon: 36.8;duodenum: 24.4;gallbladder: 9.5;kidney: 45.4;rectum: 36.2;small intestine: 35.4 appendix: 3.7 SMIM24 C19orf77, HSPC323 ENSG00000095932 Small integral membrane protein 24 19 3473986-3480542 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA045046, HPA056027 Supported Approved Nucleoplasm
Cytosol Group enriched 8 duodenum: 780.7;epididymis: 1898.5;kidney: 832.6;small intestine: 696.9 stomach: 139.3 ASPDH ENSG00000204653 Aspartate dehydrogenase domain containing 19 50511600-50514690 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042631, HPA042654 Approved Group enriched 7 cerebral cortex: 17.9;duodenum: 7.1;kidney: 27.9;liver: 34.6 adrenal gland: 3.3 BBOX1 BBH, BBOX, G-BBH, gamma-BBH ENSG00000129151 Butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 11 27040725-27127809 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007600, HPA027823 Supported Approved Tissue enriched 7 kidney: 469.2 liver: 66.0 CLEC18A MRCL ENSG00000157322 C-type lectin domain family 18, member A 16 69950705-69964452 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA048976 Uncertain Group enriched 7 kidney: 15.6;testis: 3.7 adrenal gland: 1.3 CRYAA CRYA1, HSPB4 ENSG00000160202 Crystallin, alpha A 21 43169008-43172805 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA037737 Approved Nucleoplasm
Cytosol Tissue enriched 7 kidney: 12.4 liver: 1.7 EGF ENSG00000138798 Epidermal growth factor 4 109912884-110012266 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 7 kidney: 121.1 pancreas: 18.5 EHHADH ECHD ENSG00000113790 Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase 3 185190624-185281990 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036401, HPA042021 Supported Group enriched 7 kidney: 147.7;liver: 173.2 duodenum: 22.0 GCGR GGR ENSG00000215644 Glucagon receptor 17 81804132-81814013 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071228 Approved Golgi apparatus Group enriched 7 adrenal gland: 6.6;kidney: 8.5;liver: 20.9;parathyroid gland: 9.4 skin: 1.6 HNF4A HNF4, MODY, MODY1, NR2A1, TCF14 ENSG00000101076 Hepatocyte nuclear factor 4, alpha 20 44355700-44434596 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004712, CAB019417 Supported Supported Nucleoplasm Group enriched 7 colon: 58.9;duodenum: 105.9;kidney: 44.3;liver: 50.9;rectum: 48.5;small intestine: 92.8;stomach: 22.1 gallbladder: 9.2 KCNJ16 BIR9, Kir5.1 ENSG00000153822 Potassium channel, inwardly rectifying subfamily J, member 16 17 70053429-70135608 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA059563 Approved Uncertain Vesicles Group enriched 7 kidney: 207.9;parathyroid gland: 268.8;thyroid gland: 233.9 seminal vesicle: 31.9 PIPOX LPIPOX ENSG00000179761 Pipecolic acid oxidase 17 28950513-29057220 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 7 kidney: 136.7;liver: 235.2 epididymis: 26.2 PTGER3 EP3 ENSG00000050628 Prostaglandin E receptor 3 (subtype EP3) 1 70852353-71047808 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA010689 Uncertain Group enriched 7 adipose tissue: 58.5;endometrium: 114.7;kidney: 87.6;smooth muscle: 103.9 skin: 14.0 SLC13A3 NADC3, SDCT2 ENSG00000158296 Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 20 46557823-46684467 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014353, HPA014736 Supported Tissue enriched 7 kidney: 428.6 placenta: 60.6 SLC17A1 NAPI-1, NPT1 ENSG00000124568 Solute carrier family 17 (organic anion transporter), member 1 6 25782897-25832059 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA050513 Approved Golgi apparatus Tissue enriched 7 kidney: 173.1 liver: 25.2 TINAG ENSG00000137251 Tubulointerstitial nephritis antigen 6 54307859-54390152 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035427, HPA041055 Approved Approved Vesicles Tissue enriched 7 kidney: 112.9 small intestine: 16.0 TMEM72 bA285G1.3, C10orf127, KSP37 ENSG00000187783 Transmembrane protein 72 10 44911200-44937002 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA039894, HPA062907 Supported Tissue enriched 7 kidney: 54.0 rectum: 8.0 UGT2A1 ENSG00000173610 UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus 4 69588417-69653249 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA017261, HPA045108 Uncertain Group enriched 7 kidney: 8.1;liver: 5.5 skin: 0.9 ACE2 ENSG00000130234 Angiotensin I converting enzyme 2 X 15561033-15602148 Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000288, CAB026174 Supported Group enriched 6 duodenum: 186.1;gallbladder: 100.6;kidney: 93.3;small intestine: 266.6;testis: 92.6 heart muscle: 23.1 ACY1 ENSG00000243989 Aminoacylase 1 3 51983340-51989197 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003695, HPA036174, HPA036175 Supported Group enriched 6 duodenum: 182.6;kidney: 462.6;liver: 146.9;small intestine: 158.4 thyroid gland: 40.0 AMN amnionless ENSG00000166126 Amnion associated transmembrane protein 14 102922656-102933596 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA000817 Approved Group enriched 6 colon: 20.4;duodenum: 35.1;kidney: 29.0;small intestine: 72.0 liver: 6.8 AP000322.53 ENSG00000243627 21 34418715-34423966 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA029085 Uncertain Group enriched 6 breast: 3.3;fallopian tube: 3.2;kidney: 8.7 epididymis: 0.9 ARSF ENSG00000062096 Arylsulfatase F X 3041471-3112726 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA000549 Uncertain Cytosol Group enriched 6 adrenal gland: 4.0;cerebral cortex: 2.1;epididymis: 2.1;esophagus: 2.3;kidney: 8.0;skin: 6.7 urinary bladder: 0.6 BHMT2 ENSG00000132840 Betaine--homocysteine S-methyltransferase 2 5 79069717-79089466 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044573 Supported Group enriched 6 kidney: 360.3;liver: 238.4 epididymis: 46.4 BSND BART, DFNB73 ENSG00000162399 Barttin CLCNK-type chloride channel accessory beta subunit 1 54998933-55010883 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053836 Supported Tissue enriched 6 kidney: 10.2 salivary gland: 1.5 CDC20B FLJ37927 ENSG00000164287 Cell division cycle 20B 5 55112995-55173175 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA053900 Uncertain Group enriched 6 endometrium: 1.2;fallopian tube: 3.4;kidney: 1.2;testis: 4.7 lung: 0.4 CLDN16 HOMG3, PCLN1 ENSG00000113946 Claudin 16 3 190322541-190412143 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA056020 Supported Tissue enriched 6 kidney: 51.3 thyroid gland: 8.7 CRYM DFNA40 ENSG00000103316 Crystallin, mu 16 21238874-21303083 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019086, HPA030619 Supported Supported Cytosol Group enriched 6 cerebral cortex: 102.6;heart muscle: 98.1;kidney: 56.5;prostate: 52.7;urinary bladder: 30.8 lung: 11.5 CYP4F2 ENSG00000186115 Cytochrome P450, family 4, subfamily F, polypeptide 2 19 15878023-15898120 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014048, HPA017265, HPA058960 Supported Group enriched 6 duodenum: 80.4;epididymis: 27.5;kidney: 39.1;liver: 84.6;small intestine: 86.1 prostate: 10.6 CYS1 ENSG00000205795 Cystin 1 2 10056780-10080944 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 6 kidney: 100.7 ovary: 15.7 DCXR DCR, KIDCR, SDR20C1 ENSG00000169738 Dicarbonyl/L-xylulose reductase 17 82035136-82037732 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023371, HPA023863 Supported Uncertain Nucleoli
Microtubules Group enriched 6 epididymis: 292.3;kidney: 216.4;liver: 638.6;prostate: 134.3 adipose tissue: 56.5 DNMT3L MGC1090 ENSG00000142182 DNA (cytosine-5-)-methyltransferase 3-like 21 44246339-44262216 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA055234, HPA066780 Uncertain Approved Nuclear speckles Group enriched 6 kidney: 7.4;liver: 10.8;lymph node: 2.3 spleen: 1.1 ESRRB DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2 ENSG00000119715 Estrogen-related receptor beta 14 76310614-76501841 Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 heart muscle: 2.5;kidney: 5.2;skeletal muscle: 1.7;stomach: 1.5;testis: 1.4 breast: 0.3 FXYD2 ATP1G1, HOMG2, MGC12372 ENSG00000137731 FXYD domain containing ion transport regulator 2 11 117800844-117828698 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064218, HPA068838 Supported Approved Mitochondria Group enriched 6 gallbladder: 575.2;kidney: 1428.7;salivary gland: 383.4 pancreas: 134.6 GATM AGAT ENSG00000171766 Glycine amidinotransferase (L-arginine:glycine amidinotransferase) 15 45361124-45402327 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026077 Supported Supported Mitochondria Group enriched 6 kidney: 1889.7;liver: 1289.2;pancreas: 573.5 ovary: 194.5 GGACT A2LD1 ENSG00000134864 Gamma-glutamylamine cyclotransferase 13 100530164-100589528 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA065320 Approved Tissue enriched 6 kidney: 75.5 testis: 12.4 HMX2 NKX5-2 ENSG00000188816 H6 family homeobox 2 10 123148122-123150672 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043379 Uncertain Tissue enriched 6 kidney: 1.2 duodenum: 0.2 KCNJ10 Kir1.2, Kir4.1 ENSG00000177807 Potassium channel, inwardly rectifying subfamily J, member 10 1 160037467-160070248 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 120.1;kidney: 27.8 spleen: 13.3 LHX1 LIM-1, LIM1 ENSG00000273706 LIM homeobox 1 17 36936785-36944612 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB002770 Uncertain Tissue enriched 6 kidney: 1.3 fallopian tube: 0.2 LRP2 DBS, gp330 ENSG00000081479 Low density lipoprotein receptor-related protein 2 2 169127109-169362685 Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005980, HPA064792 Supported Approved Vesicles
Mitochondria Group enriched 6 kidney: 49.4;parathyroid gland: 153.0;thyroid gland: 36.8 breast: 14.1 PCK2 PEPCK, PEPCK2 ENSG00000100889 Phosphoenolpyruvate carboxykinase 2 (mitochondrial) 14 24094053-24110598 Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018734, HPA051162, HPA053502 Supported Validated Mitochondria Group enriched 6 duodenum: 377.7;kidney: 191.6;liver: 258.5;small intestine: 282.4 colon: 47.9 PDZK1IP1 DD96, MAP17, SPAP ENSG00000162366 PDZK1 interacting protein 1 1 47183593-47191044 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014907 Approved Approved Nuclear speckles
Cytosol Group enriched 6 gallbladder: 299.6;kidney: 1048.6 esophagus: 121.8 PLPPR1 FLJ20300, LPPR1, MGC26189, PRG-3 ENSG00000148123 Phospholipid phosphatase related 1 9 101028709-101325135 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014760, HPA014968, HPA014979 Supported Approved Nucleoplasm Group enriched 6 cerebral cortex: 23.9;kidney: 15.7 epididymis: 3.2 SLC13A1 NAS1, NaSi-1 ENSG00000081800 Solute carrier family 13 (sodium/sulfate symporter), member 1 7 123113531-123199986 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA053615, HPA062714 Approved Tissue enriched 6 kidney: 84.4 small intestine: 14.3 SLC5A11 KST1, SGLT6, SMIT2 ENSG00000158865 Solute carrier family 5 (sodium/inositol cotransporter), member 11 16 24845841-24911628 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035331 Uncertain Approved Nucleus
Cytosol Group enriched 6 cerebral cortex: 10.5;duodenum: 6.8;kidney: 6.0;small intestine: 15.5 breast: 1.7 STAP1 BRDG1, STAP-1 ENSG00000035720 Signal transducing adaptor family member 1 4 67558728-67607337 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038529 Supported Uncertain Nucleoplasm
Vesicles Group enriched 6 appendix: 24.7;kidney: 13.1;lymph node: 60.3;spleen: 27.0;tonsil: 58.9 testis: 6.1 UGT1A6 GNT1, HLUGP, UGT1F ENSG00000167165 UDP glucuronosyltransferase 1 family, polypeptide A6 2 233691607-233773300 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009819, HPA054065 Supported Group enriched 6 kidney: 74.7;liver: 71.9;urinary bladder: 112.0 esophagus: 15.2 WDR72 FLJ38736 ENSG00000166415 WD repeat domain 72 15 53513741-53762878 Disease related genes, Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA048212, HPA057410, HPA059819 Uncertain Approved Vesicles Group enriched 6 kidney: 103.9;thyroid gland: 91.7 liver: 17.1 ZFAT KIAA1485, ZFAT1, ZNF406 ENSG00000066827 Zinc finger and AT hook domain containing 8 134477788-134713049 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020989, HPA063592 Supported Approved Nucleoplasm
Nuclear bodies Group enriched 6 kidney: 10.4;placenta: 44.0 testis: 4.4 AOX1 AO, AOH1 ENSG00000138356 Aldehyde oxidase 1 2 200585868-200677064 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040199, HPA040215 Approved Supported Nuclear bodies
Cytosol Group enriched 5 adrenal gland: 370.6;kidney: 96.7;liver: 432.0 ovary: 56.6 EMX2 ENSG00000170370 Empty spiracles homeobox 2 10 117542444-117549546 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA003497, HPA065294 Approved Supported Approved Nucleus Group enriched 5 cervix, uterine: 59.4;endometrium: 114.7;epididymis: 113.9;fallopian tube: 72.9;kidney: 38.3;seminal vesicle: 64.9;smooth muscle: 59.6 cerebral cortex: 14.0 ENPEP CD249, gp160 ENSG00000138792 Glutamyl aminopeptidase (aminopeptidase A) 4 110365733-110565285 CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005128 Approved Group enriched 5 duodenum: 37.5;kidney: 93.6;parathyroid gland: 157.9;small intestine: 183.8 placenta: 21.5 GSTA2 GST2 ENSG00000244067 Glutathione S-transferase alpha 2 6 52750089-52763569 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004342, HPA048934, HPA053817 Supported Supported Cytosol Group enriched 5 kidney: 646.8;liver: 983.1 gallbladder: 156.1 HAVCR1 CD365, HAVCR, HAVCR-1, TIM-1, TIM1, TIMD1 ENSG00000113249 Hepatitis A virus cellular receptor 1 5 157029413-157059119 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA007173 Approved Vesicles Group enriched 5 colon: 4.9;kidney: 8.2;rectum: 4.2;testis: 1.7 parathyroid gland: 0.9 KL ENSG00000133116 Klotho 13 33016433-33066145 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 kidney: 135.6;parathyroid gland: 340.1 placenta: 43.7 LYG1 SALW1939 ENSG00000144214 Lysozyme G-like 1 2 99284238-99304742 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 5 kidney: 21.9;testis: 4.8 breast: 2.5 MYO3B ENSG00000071909 Myosin IIIB 2 170178145-170655171 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015745, HPA045483 Uncertain Group enriched 5 epididymis: 11.2;kidney: 4.6;parathyroid gland: 14.8;urinary bladder: 4.3 thyroid gland: 1.6 MYOM3 FLJ35961 ENSG00000142661 Myomesin 3 1 24056035-24112175 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA028132, HPA029752 Uncertain Approved Vesicles Group enriched 5 heart muscle: 68.0;kidney: 31.7;skeletal muscle: 86.6 testis: 12.1 NPR3 ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC ENSG00000113389 Natriuretic peptide receptor 3 5 32689070-32791724 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031065, HPA052702 Uncertain Approved Cytosol Tissue enriched 5 kidney: 113.3 adipose tissue: 21.9 PAX2 ENSG00000075891 Paired box 2 10 100735603-100829941 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level CAB013024, HPA047704, HPA070751 Supported Supported Nucleoli
Golgi apparatus Group enriched 5 epididymis: 36.6;fallopian tube: 18.8;kidney: 25.2;seminal vesicle: 19.8 cervix: 4.9 PKHD1 ARPKD, FCYT, TIGM1 ENSG00000170927 Polycystic kidney and hepatic disease 1 (autosomal recessive) 6 51615300-52087625 Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031227 Supported Group enriched 5 epididymis: 5.7;kidney: 15.2 pancreas: 1.9 RNF152 FLJ39176 ENSG00000176641 Ring finger protein 152 18 61808063-61894247 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 5 kidney: 56.2 liver: 10.3 RP11-407N17.3 ENSG00000258941 14 39233902-39350423 Predicted membrane proteins Evidence at protein level Evidence at protein level HPA000387, HPA000922, HPA054066, HPA055459 Uncertain Approved Endoplasmic reticulum Group enriched 5 duodenum: 16.1;kidney: 10.3;liver: 13.3;parathyroid gland: 21.0;small intestine: 19.1 gallbladder: 3.0 SLC23A1 SLC23A2, SVCT1, YSPL3 ENSG00000170482 Solute carrier family 23 (ascorbic acid transporter), member 1 5 139367196-139384553 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047612 Supported Group enriched 5 duodenum: 27.5;fallopian tube: 85.7;kidney: 41.7;small intestine: 73.4 liver: 10.7 SLC27A2 ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS ENSG00000140284 Solute carrier family 27 (fatty acid transporter), member 2 15 50182196-50236395 Enzymes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026089 Supported Group enriched 5 epididymis: 79.2;kidney: 160.9;liver: 145.2 placenta: 24.5 SLC47A2 FLJ31196, MATE2, MATE2-K ENSG00000180638 Solute carrier family 47 (multidrug and toxin extrusion), member 2 17 19678288-19718979 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 fallopian tube: 16.0;kidney: 48.9 epididymis: 6.0 SSC4D S4D-SRCRB, SRCRB-S4D, SRCRB4D ENSG00000146700 Scavenger receptor cysteine rich family, 4 domains 7 76389334-76409695 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA062611 Uncertain Group enriched 5 kidney: 1.4;parathyroid gland: 4.1;thyroid gland: 2.0 cervix: 0.5 TAL2 bHLHa19 ENSG00000186051 T-cell acute lymphocytic leukemia 2 9 105662457-105663112 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA030886 Uncertain Approved Cytosol Group enriched 5 kidney: 3.4;skeletal muscle: 4.8 epididymis: 0.8 TMEM132E DFNB99 ENSG00000181291 Transmembrane protein 132E 17 34580749-34639318 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA070608 Approved Group enriched 5 cerebral cortex: 4.8;duodenum: 1.7;kidney: 3.2;small intestine: 1.1;testis: 1.5 cervix: 0.4 ABAT GABAT ENSG00000183044 4-aminobutyrate aminotransferase 16 8674565-8784575 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041528, HPA041690 Supported Supported Mitochondria Tissue enhanced 0 cerebral cortex: 165.0;kidney: 134.3;liver: 175.2 thyroid gland: 47.2 ABCC6 ARA, EST349056, MLP1, MRP6, PXE, URG7 ENSG00000091262 ATP-binding cassette, sub-family C (CFTR/MRP), member 6 16 16148928-16223522 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038105 Supported Plasma membrane Tissue enhanced 0 kidney: 15.2;liver: 19.1 duodenum: 11.6 ACOT4 FLJ31235, PTE-Ib, PTE2B ENSG00000177465 Acyl-CoA thioesterase 4 14 73591706-73596496 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000779 Approved Tissue enhanced 0 kidney: 8.9 liver: 4.9 ACOT6 C14orf42 ENSG00000205669 Acyl-CoA thioesterase 6 14 73610945-73619888 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA058258 Uncertain Tissue enhanced 0 kidney: 4.8 liver: 3.1 ACSF2 ACSMW, FLJ20920 ENSG00000167107 Acyl-CoA synthetase family member 2 17 50426158-50474845 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024693 Approved Approved Nucleoplasm
Microtubules
Cytosol Tissue enhanced 0 kidney: 136.1 thyroid gland: 68.3 ACY3 ACY-3, HCBP1, MGC9740 ENSG00000132744 Aminoacylase 3 11 67642555-67650659 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039219, HPA048187 Supported Tissue enhanced 0 duodenum: 82.8;kidney: 53.1;small intestine: 80.3 cervix: 16.0 ADGRF1 GPR110, hGPCR36, PGR19 ENSG00000153292 Adhesion G protein-coupled receptor F1 6 46997703-47042363 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA038438 Approved Tissue enhanced 0 esophagus: 14.7;kidney: 17.6;urinary bladder: 19.6 gallbladder: 9.5 AGMAT FLJ23384 ENSG00000116771 Agmatine ureohydrolase (agmatinase) 1 15572353-15585110 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026443, HPA028321 Supported Tissue enhanced 0 kidney: 157.9 liver: 36.6 AIF1L C9orf58, FLJ12783, IBA2 ENSG00000126878 Allograft inflammatory factor 1-like 9 131096476-131123152 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020522, HPA056852 Supported Tissue enhanced 0 kidney: 286.8;spleen: 292.5 thyroid gland: 154.8 AK4 AK3, AK3L1 ENSG00000162433 Adenylate kinase 4 1 65147549-65232145 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042753, HPA049461 Supported Supported Mitochondria Tissue enhanced 0 kidney: 189.1 liver: 53.6 AL137860.1 ENSG00000280403 1 27064991-27065365 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level HPA042797 Uncertain Tissue enhanced 0 breast: 11.5;kidney: 9.5 duodenum: 7.1 ALDH1L1 10-fTHF, FTHFD ENSG00000144908 Aldehyde dehydrogenase 1 family, member L1 3 126103562-126197994 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036900, HPA050139 Approved Supported Cytosol Tissue enhanced 0 kidney: 123.5;liver: 191.5 adipose tissue: 82.2 ALDH4A1 ALDH4, P5CDh ENSG00000159423 Aldehyde dehydrogenase 4 family, member A1 1 18871430-18902781 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004645, HPA006401 Approved Tissue enhanced 0 kidney: 184.9;liver: 108.1 adipose tissue: 63.7 ALX1 CART1 ENSG00000180318 ALX homeobox 1 12 85280107-85301784 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001598, HPA018905 Uncertain Supported Nucleoplasm
Nuclear bodies
Golgi apparatus Tissue enhanced 0 epididymis: 4.2;kidney: 3.1 ovary: 1.8 ARSE CDPX, CDPX1 ENSG00000157399 Arylsulfatase E (chondrodysplasia punctata 1) X 2934632-2968310 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA060518 Supported Golgi apparatus Tissue enhanced 0 kidney: 41.1;liver: 49.1 pancreas: 23.9 ASPA ACY2, ASP ENSG00000108381 Aspartoacylase 17 3472374-3503419 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA022142, HPA022145 Approved Uncertain Cytosol Tissue enhanced 0 kidney: 39.5 cerebral cortex: 24.8 ASS1 ASS, CTLN1 ENSG00000130707 Argininosuccinate synthase 1 9 130444929-130501274 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020896, HPA020934 Supported Approved Nucleoplasm
Cytosol Tissue enhanced 0 kidney: 1253.5;liver: 1027.3 fallopian tube: 258.7 C14orf105 FLJ10650 ENSG00000100557 Chromosome 14 open reading frame 105 14 57469301-57493867 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA029202 Uncertain Nucleus
Cytosol Tissue enhanced 0 fallopian tube: 43.3;gallbladder: 27.2;kidney: 63.2 liver: 11.3 C21orf62 B37, C21orf120, PRED81 ENSG00000205929 Chromosome 21 open reading frame 62 21 32790674-32813743 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA016899, CAB034173 Approved Tissue enhanced 0 epididymis: 7.0;kidney: 5.4;ovary: 12.5 prostate: 3.7 C9orf66 FLJ31158 ENSG00000183784 Chromosome 9 open reading frame 66 9 212824-215741 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA035652 Uncertain Tissue enhanced 0 kidney: 17.7 adrenal gland: 4.1 CA12 HsT18816 ENSG00000074410 Carbonic anhydrase XII 15 63321378-63382161 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008773, CAB025181, CAB062549, CAB068179, HPA073203 Supported Approved Nucleus
Vesicles Tissue enhanced 0 kidney: 307.3;skin: 168.7 rectum: 105.5 CALCR CTR ENSG00000004948 Calcitonin receptor 7 93424487-93574730 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level HPA028962 Uncertain Tissue enhanced 0 kidney: 2.1;testis: 1.4 placenta: 0.9 CCDC64 FLJ26450 ENSG00000135127 Coiled-coil domain containing 64 12 119989869-120094494 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA061116 Approved Approved Nucleoplasm
Vesicles
Cytosol Tissue enhanced 0 kidney: 73.5;skin: 58.8 epididymis: 45.0 CH507-9B2.2 ENSG00000279493 21 5011799-5017145 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 kidney: 1.8;liver: 3.1 lymph node: 0.5 CHDH ENSG00000016391 Choline dehydrogenase 3 53812335-53846390 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036633, HPA058130 Supported Tissue enhanced 0 kidney: 39.9 small intestine: 16.7 CLCN5 ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN ENSG00000171365 Chloride channel, voltage-sensitive 5 X 49922615-50099235 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000401, HPA003213 Uncertain Supported Golgi apparatus
Plasma membrane
Cytosol Tissue enhanced 0 epididymis: 33.2;kidney: 51.6 placenta: 9.5 CLCNKB hClC-Kb ENSG00000184908 Chloride channel, voltage-sensitive Kb 1 16043736-16057308 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057717 Approved Tissue enhanced 0 kidney: 107.5 salivary gland: 22.1 CLDN10 CPETRL3, OSP-L ENSG00000134873 Claudin 10 13 95433604-95579759 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB012969, HPA042348 Supported Tissue enhanced 0 kidney: 161.8 gallbladder: 111.0 CLDN2 ENSG00000165376 Claudin 2 X 106900164-106930861 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002609, HPA051548 Supported Supported Nucleoplasm
Cell Junctions Tissue enhanced 0 gallbladder: 159.7;kidney: 170.5;seminal vesicle: 128.0 epididymis: 40.4 CLDN24 CLDN21 ENSG00000185758 Claudin 24 4 183321764-183322426 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence Tissue enhanced 0 kidney: 1.0 smooth muscle: 0.2 CLDN8 ENSG00000156284 Claudin 8 21 30214006-30216073 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA060605 Approved Tissue enhanced 0 breast: 84.5;kidney: 75.5;rectum: 56.8 thyroid gland: 37.2 CLNK MIST ENSG00000109684 Cytokine-dependent hematopoietic cell linker 4 10486395-10684865 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035671, HPA035672 Uncertain Uncertain Vesicles Tissue enhanced 0 kidney: 5.8 lymph node: 3.5 CYP27B1 CYP1, P450c1, PDDR, VDD1 ENSG00000111012 Cytochrome P450, family 27, subfamily B, polypeptide 1 12 57762334-57768986 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 4.7;thyroid gland: 4.1 appendix: 1.3 DCDC2 DCDC2A, KIAA1154, NPHP19, RU2 ENSG00000146038 Doublecortin domain containing 2 6 24171756-24358052 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031582, HPA031583, HPA031584 Supported Validated Nucleus
Cytosol Tissue enhanced 0 kidney: 23.0 parathyroid gland: 15.2 DDC AADC ENSG00000132437 Dopa decarboxylase (aromatic L-amino acid decarboxylase) 7 50458436-50565457 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017742 Supported Approved Actin filaments Tissue enhanced 0 duodenum: 159.5;kidney: 318.7;small intestine: 184.3 adrenal gland: 64.1 DEFB1 BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822 ENSG00000164825 Defensin, beta 1 8 6870575-6878022 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cervix, uterine: 614.0;kidney: 1487.1 salivary gland: 233.8 DHDH HUM2DD ENSG00000104808 Dihydrodiol dehydrogenase (dimeric) 19 48933682-48944969 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA044131 Approved Approved Nucleoplasm
Actin filaments Tissue enhanced 0 duodenum: 10.5;kidney: 17.8;small intestine: 19.0 prostate: 4.6 DPEP1 ENSG00000015413 Dipeptidase 1 (renal) 16 89613308-89638456 Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009426, HPA012783 Supported Approved Nucleus
Cell Junctions Tissue enhanced 0 kidney: 262.3;small intestine: 426.5 pancreas: 92.8 EMX1 ENSG00000135638 Empty spiracles homeobox 1 2 72916260-72936071 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA006230, HPA006421 Uncertain Approved Nucleoli Tissue enhanced 0 cerebral cortex: 8.3;kidney: 15.5;parathyroid gland: 5.1 testis: 2.6 ENAM AIH2 ENSG00000132464 Enamelin 4 70628744-70686816 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 epididymis: 8.1;kidney: 5.8 heart muscle: 2.6 ENPP6 MGC33971 ENSG00000164303 Ectonucleotide pyrophosphatase/phosphodiesterase 6 4 184088706-184221230 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042740 Approved Uncertain Golgi apparatus Tissue enhanced 0 kidney: 30.5;ovary: 15.0 cerebral cortex: 8.7 ESM1 ENSG00000164283 Endothelial cell-specific molecule 1 5 54977864-55022671 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 19.1;thyroid gland: 27.2 endometrium: 5.7 ETNK2 EKI2, FLJ10761 ENSG00000143845 Ethanolamine kinase 2 1 204131062-204152003 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA057167 Supported Tissue enhanced 0 kidney: 109.8;liver: 119.6;testis: 142.1 ovary: 43.3 FAM131C C1orf117, FLJ36766 ENSG00000185519 Family with sequence similarity 131, member C 1 16057769-16073632 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA031046 Uncertain Approved Nucleoli
Intermediate filaments
Cytosol Tissue enhanced 0 adrenal gland: 3.3;cerebral cortex: 4.8;kidney: 3.8 heart muscle: 1.2 FAM24B AC073585.2, MGC45962 ENSG00000213185 Family with sequence similarity 24, member B 10 122849078-122879641 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA052490 Uncertain Tissue enhanced 0 kidney: 13.7 testis: 11.4 FCAMR CD351, FCA/MR, FKSG87 ENSG00000162897 Fc receptor, IgA, IgM, high affinity 1 206957965-206970625 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 kidney: 32.0;lymph node: 14.1;tonsil: 11.7 appendix: 5.4 FGF1 AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1 ENSG00000113578 Fibroblast growth factor 1 (acidic) 5 142592178-142698070 Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003265, CAB017519 Supported Validated Nucleoplasm Tissue enhanced 0 cerebral cortex: 130.3;kidney: 59.1 heart muscle: 32.8 FGF9 ENSG00000102678 Fibroblast growth factor 9 13 21671383-21704498 Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB004392 Uncertain Tissue enhanced 0 kidney: 12.0 adrenal gland: 4.7 FMO4 FMO2 ENSG00000076258 Flavin containing monooxygenase 4 1 171314208-171342084 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049100 Uncertain Tissue enhanced 0 kidney: 47.7;liver: 30.1 parathyroid gland: 10.7 FOXI1 FKHL10, FREAC6 ENSG00000168269 Forkhead box I1 5 170105897-170109725 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA071469 Supported Uncertain Nucleoli
Vesicles Tissue enhanced 0 breast: 10.4;kidney: 19.9;prostate: 6.5 salivary gland: 6.3 FREM2 DKFZp686J0811 ENSG00000150893 FRAS1 related extracellular matrix protein 2 13 38687129-38887131 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA028831 Uncertain Approved Cytosol Tissue enhanced 0 kidney: 8.2;thyroid gland: 8.2 lung: 3.3 FRMD7 FLJ43346, NYS, NYS1 ENSG00000165694 FERM domain containing 7 X 132076993-132128020 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA000886 Uncertain Tissue enhanced 0 endometrium: 2.8;kidney: 3.0;smooth muscle: 3.4 seminal vesicle: 0.7 FUT6 FCT3A, FLJ40754, FT1A, FucT-VI ENSG00000156413 Fucosyltransferase 6 (alpha (1,3) fucosyltransferase) 19 5830610-5839731 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043707, HPA046966 Approved Supported Golgi apparatus Tissue enhanced 0 esophagus: 50.0;kidney: 34.3 small intestine: 31.2 FXYD6-FXYD2 ENSG00000255245 FXYD6-FXYD2 readthrough 11 117820163-117876667 Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA068838 Approved Tissue enhanced 0 kidney: 5.5 salivary gland: 2.2 G6PC G6PT, GSD1a ENSG00000131482 Glucose-6-phosphatase, catalytic subunit 17 42900797-42913369 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA052324 Approved Tissue enhanced 0 kidney: 88.4;liver: 146.8 small intestine: 33.8 GALNT14 FLJ12691, GalNac-T10, GalNac-T14 ENSG00000158089 Polypeptide N-acetylgalactosaminyltransferase 14 2 30910467-31155202 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA030138 Approved Nucleus
Golgi apparatus Tissue enhanced 0 kidney: 40.0 parathyroid gland: 12.5 GDF3 ENSG00000184344 Growth differentiation factor 3 12 7689782-7695776 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018468 Uncertain Tissue enhanced 0 kidney: 1.1;spleen: 1.1 testis: 0.8 GGH ENSG00000137563 Gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) 8 63015079-63039171 Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB019296, HPA025226 Approved Tissue enhanced 0 kidney: 89.2 liver: 62.8 GGT1 CD224, D22S672, D22S732, GGT ENSG00000100031 Gamma-glutamyltransferase 1 22 24583750-24629005 Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045635, HPA047534, HPA065444 Supported Approved Vesicles Tissue enhanced 0 kidney: 160.6 small intestine: 97.9 GK GK1, GKD ENSG00000198814 Glycerol kinase X 30653359-30731456 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060687 Approved Tissue enhanced 0 kidney: 110.2;small intestine: 100.8 duodenum: 89.7 GLDC GCSP, NKH ENSG00000178445 Glycine dehydrogenase (decarboxylating) 9 6532464-6645650 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002318, HPA052887 Supported Supported Nucleus
Mitochondria Tissue enhanced 0 kidney: 58.8;liver: 39.3;placenta: 46.9 cerebral cortex: 18.7 GLOD5 ENSG00000171433 Glyoxalase domain containing 5 X 48761750-48773648 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA010667 Uncertain Uncertain Mitochondria Tissue enhanced 0 duodenum: 11.1;kidney: 10.9;small intestine: 10.9 epididymis: 6.7 GLTPD2 ENSG00000182327 Glycolipid transfer protein domain containing 2 17 4788959-4790390 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058295, HPA065267 Uncertain Approved Vesicles Tissue enhanced 0 duodenum: 11.3;kidney: 12.9;liver: 14.0 small intestine: 7.4 GPAT3 AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324 ENSG00000138678 Glycerol-3-phosphate acyltransferase 3 4 83535914-83605875 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029414, CAB033749 Approved Uncertain Plasma membrane
Cytosol Tissue enhanced 0 kidney: 89.3 duodenum: 41.9 GPC5 ENSG00000179399 Glypican 5 13 91398607-92873682 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA040152, HPA044081 Supported Approved Nucleus
Cytosol Tissue enhanced 0 cerebral cortex: 15.9;kidney: 8.1;testis: 11.5 lung: 4.9 GRB14 ENSG00000115290 Growth factor receptor-bound protein 14 2 164492812-164621848 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022294, HPA035052, HPA035053 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 epididymis: 6.0;kidney: 6.1;liver: 6.6 testis: 4.3 GSTA1 ENSG00000243955 Glutathione S-transferase alpha 1 6 52791664-52803910 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004342, HPA048934, HPA053817 Supported Supported Cytosol Tissue enhanced 0 adrenal gland: 1142.9;kidney: 1300.7;liver: 1750.1 small intestine: 1023.4 HECW1 KIAA0322, NEDL1 ENSG00000002746 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 7 43112599-43566001 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007203, HPA007593, HPA007609 Approved Supported Cytosol Tissue enhanced 0 cerebral cortex: 10.9;kidney: 8.3 testis: 3.9 HGD AKU, HGO ENSG00000113924 Homogentisate 1,2-dioxygenase 3 120628173-120682571 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047374, HPA052359 Supported Approved Nucleus
Nucleoli Tissue enhanced 0 kidney: 174.2;liver: 322.8 gallbladder: 87.5 HNF1A HCF-1A, HNF1, LFB1, MODY3, TCF1 ENSG00000135100 HNF1 homeobox A 12 120978543-121002512 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB010430, HPA035231 Supported Supported Nucleoplasm Tissue enhanced 0 duodenum: 15.9;kidney: 10.1;small intestine: 16.0 liver: 5.8 HNF1B HNF1beta, LFB3, MODY5, TCF2, VHNF1 ENSG00000275410 HNF1 homeobox B 17 37686432-37745247 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002083, CAB068192 Supported Supported Nucleoplasm Tissue enhanced 0 gallbladder: 21.6;kidney: 25.2 lung: 9.6 HOGA1 C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2 ENSG00000241935 4-hydroxy-2-oxoglutarate aldolase 1 10 97584323-97612802 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039466 Approved Tissue enhanced 0 kidney: 53.2;liver: 20.7 adrenal gland: 8.2 HOXD8 HOX4, HOX4E ENSG00000175879 Homeobox D8 2 176129694-176132695 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 epididymis: 121.2;kidney: 83.6 ovary: 43.6 HPN TMPRSS1 ENSG00000105707 Hepsin 19 35040506-35066571 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006804 Approved Tissue enhanced 0 kidney: 99.4;liver: 155.0 prostate: 27.9 HS6ST2 ENSG00000171004 Heparan sulfate 6-O-sulfotransferase 2 X 132626016-132961395 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA034625, HPA034626 Uncertain Validated Nucleoplasm Tissue enhanced 0 kidney: 14.9;ovary: 17.6 placenta: 11.9 HSD11B2 SDR9C3 ENSG00000176387 Hydroxysteroid (11-beta) dehydrogenase 2 16 67430652-67437553 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB032443, HPA042186, HPA056385 Supported Approved Vesicles Tissue enhanced 0 colon: 154.2;kidney: 172.7 salivary gland: 123.5 IL17RB CRL4, EVI27, IL17BR, IL17RH1 ENSG00000056736 Interleukin 17 receptor B 3 53846580-53865800 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA005482 Supported Tissue enhanced 0 kidney: 62.4 cervix: 32.2 INSRR IRR ENSG00000027644 Insulin receptor-related receptor 1 156840063-156859018 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA025285 Uncertain Tissue enhanced 0 adrenal gland: 1.8;kidney: 1.4;testis: 2.2 prostate: 0.6 IRX1 IRX-5 ENSG00000170549 Iroquois homeobox 1 5 3596054-3601403 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA043160 Uncertain Supported Nucleoplasm
Golgi apparatus Tissue enhanced 0 breast: 7.7;kidney: 5.3;salivary gland: 5.7 lung: 3.6 KCNH6 erg2, HERG2, Kv11.2 ENSG00000173826 Potassium channel, voltage gated eag related subfamily H, member 6 17 63523334-63548977 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 6.1;prostate: 5.3;small intestine: 5.7 duodenum: 2.3 KCNJ15 IRKK, Kir1.3, Kir4.2 ENSG00000157551 Potassium channel, inwardly rectifying subfamily J, member 15 21 38157034-38307357 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA016702 Approved Approved Vesicles
Plasma membrane
Cytosol Tissue enhanced 0 kidney: 259.2;thyroid gland: 215.5 lung: 63.5 KCP CRIM2, FLJ33365, NET67 ENSG00000135253 Kielin/chordin-like protein 7 128862451-128910719 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 kidney: 2.7;seminal vesicle: 3.2 gallbladder: 1.5 KIF12 ENSG00000136883 Kinesin family member 12 9 114086126-114099227 Predicted intracellular proteins Evidence at protein level Evidence at protein level HPA020192, HPA024127 Uncertain Approved Mitochondria Tissue enhanced 0 gallbladder: 31.6;kidney: 37.9 thyroid gland: 28.6 KLHDC7A FLJ38753 ENSG00000179023 Kelch domain containing 7A 1 18480982-18486126 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056616 Uncertain Approved Nuclear speckles Tissue enhanced 0 kidney: 20.7 urinary bladder: 6.6 KMO ENSG00000117009 Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) 1 241532134-241595642 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031115, HPA056942 Supported Tissue enhanced 0 kidney: 31.3;liver: 46.5 spleen: 10.8 LGSN GLULD1, LGS ENSG00000146166 Lengsin, lens protein with glutamine synthetase domain 6 63275951-63319977 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030957, HPA039983 Supported Approved Nucleoplasm
Vesicles Tissue enhanced 0 kidney: 2.8;liver: 2.4;placenta: 1.8 testis: 0.7 MEI4 ENSG00000269964 Meiotic double-stranded break formation protein 4 6 77690658-77926974 Predicted secreted proteins Evidence at transcript level Evidence at transcript level No evidence Tissue enhanced 0 kidney: 4.5;testis: 4.8;thyroid gland: 3.9 adrenal gland: 0.9 MFSD4 DKFZp761N1114, FLJ25004, FLJ34577, UNQ3064 ENSG00000174514 Major facilitator superfamily domain containing 4 1 205568885-205602918 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 75.1;stomach: 108.2 cerebral cortex: 50.8 MME CALLA, CD10, NEP ENSG00000196549 Membrane metallo-endopeptidase 3 155024124-155183729 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000013, HPA052583, HPA056072 Supported Tissue enhanced 0 duodenum: 440.1;kidney: 381.4;small intestine: 410.3 prostate: 151.9 MRO B29, C18orf3, FLJ30140 ENSG00000134042 Maestro 18 50795120-50825402 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA022011 Approved Tissue enhanced 0 cerebral cortex: 27.6;kidney: 25.3;testis: 54.6 thyroid gland: 10.4 MT1F MT1 ENSG00000198417 Metallothionein 1F 16 56657694-56660698 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 kidney: 283.9;thyroid gland: 816.1 small intestine: 141.3 MT1G MT1, MT1K ENSG00000125144 Metallothionein 1G 16 56666731-56668065 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 kidney: 2338.0;thyroid gland: 4892.9 liver: 1261.9 MT1H MT1 ENSG00000205358 Metallothionein 1H 16 56669814-56671129 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 kidney: 498.5;small intestine: 342.1;thyroid gland: 541.5 liver: 134.0 MTNR1A MEL-1A-R ENSG00000168412 Melatonin receptor 1A 4 186533655-186555567 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 2.2;testis: 1.9 colon: 1.2 NELL1 FLJ45906, IDH3GL ENSG00000165973 Neural EGFL like 1 11 20669551-21575681 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA051535 Approved Tissue enhanced 0 cerebral cortex: 22.9;kidney: 18.6 prostate: 8.2 NPHS1 CNF, NPHN ENSG00000161270 Nephrosis 1, congenital, Finnish type (nephrin) 19 35825964-35869287 Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB035555 Supported Tissue enhanced 0 kidney: 17.7;lymph node: 5.5;pancreas: 5.5 tonsil: 2.4 OGDHL FLJ10851 ENSG00000197444 Oxoglutarate dehydrogenase-like 10 49734643-49762379 Citric acid cycle related proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052497 Approved Approved Nucleus
Nucleoli fibrillar center
Cytosol Tissue enhanced 0 kidney: 127.9;parathyroid gland: 55.3 liver: 41.6 OTOGL C12orf64, FLJ90579 ENSG00000165899 Otogelin-like 12 80209453-80379090 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA040364, HPA053392 Uncertain Approved Cytosol Tissue enhanced 0 kidney: 6.1 heart muscle: 1.3 PAH PH ENSG00000171759 Phenylalanine hydroxylase 12 102836885-102958410 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028407, HPA031642 Supported Approved Endoplasmic reticulum
Vesicles Tissue enhanced 0 kidney: 500.3;liver: 720.9 gallbladder: 126.2 PANK1 MGC24596, PANK, PANK1a, PANK1b ENSG00000152782 Pantothenate kinase 1 10 89579497-89645572 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 kidney: 46.3;liver: 55.0 duodenum: 21.2 PAQR5 FLJ20190, MPRG ENSG00000137819 Progestin and adipoQ receptor family member V 15 69298947-69407780 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA076729 Approved Vesicles Tissue enhanced 0 kidney: 55.6 adrenal gland: 20.9 PCK1 PEPCK-C ENSG00000124253 Phosphoenolpyruvate carboxykinase 1 (soluble) 20 57561080-57568112 Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006277, HPA006507, CAB017027 Approved Tissue enhanced 0 kidney: 423.6;liver: 320.1 small intestine: 160.7 PCSK1N SAAS, SCG8, SgVIII ENSG00000102109 Proprotein convertase subtilisin/kexin type 1 inhibitor X 48831094-48835633 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003925, HPA064734 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 93.9;kidney: 65.8 adrenal gland: 28.6 PDZD3 FLJ22756, IKEPP, PDZK2 ENSG00000172367 PDZ domain containing 3 11 119185457-119190223 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 duodenum: 17.8;kidney: 10.8;small intestine: 21.6 rectum: 6.8 PDZK1 NHERF3, PDZD1 ENSG00000174827 PDZ domain containing 1 1 145670852-145708148 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005755, HPA006155, CAB008971 Supported Supported Endoplasmic reticulum
Vesicles Tissue enhanced 0 kidney: 557.9;small intestine: 129.6 duodenum: 70.9 PKLR ENSG00000143627 Pyruvate kinase, liver and RBC 1 155289839-155301434 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006653, CAB034376, CAB034378 Supported Approved Cytosol Tissue enhanced 0 kidney: 14.0;liver: 26.4 bone marrow: 7.8 PM20D1 Cps1, FLJ32569 ENSG00000162877 Peptidase M20 domain containing 1 1 205828022-205850132 Enzymes, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 kidney: 5.9;pancreas: 16.6 skin: 3.9 PRR35 C16orf11 ENSG00000161992 Proline rich 35 16 560422-565528 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA069297 Uncertain Tissue enhanced 0 kidney: 2.9 testis: 0.8 PTGER1 EP1 ENSG00000160951 Prostaglandin E receptor 1 (subtype EP1), 42kDa 19 14472466-14475362 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 kidney: 2.9;spleen: 2.6 lung: 0.7 PTH1R PTHR, PTHR1 ENSG00000160801 Parathyroid hormone 1 receptor 3 46877746-46903799 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA007978 Approved Tissue enhanced 0 kidney: 158.5 adrenal gland: 36.8 RALYL HNRPCL3 ENSG00000184672 RALY RNA binding protein-like 8 84182787-84921844 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055868, HPA059112 Supported Supported Nucleoplasm Tissue enhanced 0 adrenal gland: 26.2;cerebral cortex: 49.3;kidney: 19.6 gallbladder: 8.2 RANBP3L FLJ25422 ENSG00000164188 RAN binding protein 3-like 5 36248434-36302114 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA037471, HPA037472, HPA061526 Approved Uncertain Nucleoplasm Tissue enhanced 0 cerebral cortex: 31.1;kidney: 28.5;prostate: 21.7 breast: 10.0 RBP5 CRBPIII ENSG00000139194 Retinol binding protein 5, cellular 12 7123684-7128942 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038723 Approved Approved Golgi apparatus
Vesicles Tissue enhanced 0 kidney: 453.4;liver: 204.9 spleen: 105.3 REN ENSG00000143839 Renin 1 204154819-204166322 Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005131, CAB025903 Approved Tissue enhanced 0 kidney: 50.8;placenta: 21.0 endometrium: 8.9 RHBG SLC42A2 ENSG00000132677 Rh family, B glycoprotein (gene/pseudogene) 1 156369212-156385219 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA042726, HPA048489 Approved Approved Nucleoplasm Tissue enhanced 0 kidney: 3.5;ovary: 2.0 liver: 0.6 RIPPLY1 ENSG00000147223 Ripply transcriptional repressor 1 X 106900063-106903335 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA052284 Uncertain Tissue enhanced 0 kidney: 2.3;liver: 3.2 seminal vesicle: 1.3 RP4-583P15.14 ENSG00000273047 20 63738270-63740398 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 kidney: 1.2;liver: 2.4;urinary bladder: 1.3 adipose tissue: 1.0 SCNN1G ENaCgamma, SCNEG ENSG00000166828 Sodium channel, non voltage gated 1 gamma subunit 16 23182715-23216883 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA071194 Approved Nucleoplasm
Nucleoli
Plasma membrane Tissue enhanced 0 cervix, uterine: 24.5;kidney: 46.4 thyroid gland: 9.5 SFXN2 ENSG00000156398 Sideroflexin 2 10 102714538-102743492 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018150, HPA026834 Supported Approved Mitochondria Tissue enhanced 0 kidney: 18.8 parathyroid gland: 13.2 SHISA3 hShisa3 ENSG00000178343 Shisa family member 3 4 42397839-42402487 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA054754 Approved Lipid droplets
Cytosol Tissue enhanced 0 kidney: 24.9 lymph node: 8.8 SIM1 bHLHe14 ENSG00000112246 Single-minded family bHLH transcription factor 1 6 100385015-100464929 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA024385 Approved Nuclear speckles Tissue enhanced 0 epididymis: 3.4;kidney: 11.1;seminal vesicle: 3.1 skeletal muscle: 1.2 SIM2 bHLHe15, MGC119447, SIM ENSG00000159263 Single-minded family bHLH transcription factor 2 21 36699133-36749917 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA029295 Approved Supported Nucleoplasm
Nuclear bodies Tissue enhanced 0 esophagus: 22.9;kidney: 13.0 prostate: 9.1 SLC14A2 HUT2, UT2 ENSG00000132874 Solute carrier family 14 (urea transporter), member 2 18 45212995-45683686 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 kidney: 4.0 adipose tissue: 1.7 SLC16A12 MCT12 ENSG00000152779 Solute carrier family 16, member 12 10 89430299-89556641 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 epididymis: 62.5;kidney: 93.6 seminal vesicle: 20.0 SLC16A4 MCT4, MCT5 ENSG00000168679 Solute carrier family 16, member 4 1 110362848-110391082 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046986, HPA060163 Approved Approved Microtubules
Cytokinetic bridge
Cytosol Tissue enhanced 0 kidney: 124.3 placenta: 39.9 SLC16A9 C10orf36, FLJ43803, MCT9 ENSG00000165449 Solute carrier family 16, member 9 10 59650761-59736002 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA049286 Approved Approved Nucleus
Cell Junctions Tissue enhanced 0 adrenal gland: 199.5;kidney: 199.2 spleen: 57.0 SLC23A3 FLJ31168, SVCT3, Yspl1 ENSG00000213901 Solute carrier family 23, member 3 2 219161465-219170095 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA019059 Approved Nucleus
Cell Junctions Tissue enhanced 0 kidney: 52.7;small intestine: 23.3 duodenum: 9.0 SLC25A48 FLJ44862, HDMCP ENSG00000145832 Solute carrier family 25, member 48 5 135834649-135888637 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014674 Uncertain Approved Intermediate filaments
Actin filaments Tissue enhanced 0 cerebral cortex: 17.7;kidney: 7.3 skeletal muscle: 2.7 SLC2A9 Glut9, GLUTX, URATv1 ENSG00000109667 Solute carrier family 2 (facilitated glucose transporter), member 9 4 9771153-10054936 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA066229 Approved Tissue enhanced 0 kidney: 30.9;seminal vesicle: 29.4 duodenum: 11.1 SLC30A2 ZNT2 ENSG00000158014 Solute carrier family 30 (zinc transporter), member 2 1 26037252-26046133 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA017979 Approved Vesicles Tissue enhanced 0 kidney: 21.9;thyroid gland: 42.3 pancreas: 16.5 SLC37A4 G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d ENSG00000137700 Solute carrier family 37 (glucose-6-phosphate transporter), member 4 11 119024114-119030906 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA038939, HPA038940 Approved Approved Mitochondria Tissue enhanced 0 duodenum: 31.4;kidney: 36.1 epididymis: 20.7 SLC3A1 ATR1, CSNU1, D2H, NBAT, RBAT ENSG00000138079 Solute carrier family 3 (amino acid transporter heavy chain), member 1 2 44275458-44321494 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038360 Supported Tissue enhanced 0 kidney: 649.8 small intestine: 151.9 SLC47A1 FLJ10847, MATE1 ENSG00000142494 Solute carrier family 47 (multidrug and toxin extrusion), member 1 17 19495385-19579034 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021987 Supported Tissue enhanced 0 adrenal gland: 139.0;kidney: 105.0 liver: 55.2 SLC4A4 hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5 ENSG00000080493 Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 4 71187286-71572087 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022493, HPA035628, HPA035629 Supported Tissue enhanced 0 kidney: 124.6 cerebral cortex: 57.5 SLC5A12 MGC52019, SMCT2 ENSG00000148942 Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 11 26667019-26723427 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA060904 Supported Tissue enhanced 0 epididymis: 57.8;kidney: 172.6 small intestine: 34.0 SLC6A12 BGT-1 ENSG00000111181 Solute carrier family 6 (neurotransmitter transporter), member 12 12 190077-214570 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034973, HPA057917 Approved Approved Golgi apparatus Tissue enhanced 0 kidney: 29.4;liver: 43.6 cerebral cortex: 14.8 SLC7A7 LPI, y+LAT-1 ENSG00000155465 Solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 14 22773222-22829820 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036227 Approved Tissue enhanced 0 kidney: 279.7 parathyroid gland: 159.0 SLCO4C1 OATP-H, OATP4C1, OATPX, SLC21A20 ENSG00000173930 Solute carrier organic anion transporter family, member 4C1 5 102233986-102296549 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 kidney: 42.2 lung: 11.3 SPP1 BNSP, BSPI, ETA-1, OPN ENSG00000118785 Secreted phosphoprotein 1 4 87975650-87983426 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002212, HPA027540, HPA027541 Approved Supported Golgi apparatus Tissue enhanced 0 gallbladder: 4002.0;kidney: 2385.1;placenta: 4016.3 cerebral cortex: 797.1 STK32B HSA250839, STK32, STKG6, YANK2 ENSG00000152953 Serine/threonine kinase 32B 4 5051442-5500998 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA015820, HPA058536 Uncertain Approved Microtubules Tissue enhanced 0 kidney: 15.7 testis: 8.6 SUCNR1 GPR91 ENSG00000198829 Succinate receptor 1 3 151873643-151884619 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB022745 Uncertain Tissue enhanced 0 kidney: 42.0 thyroid gland: 15.8 SUGCT C7orf10, DERP13, FLJ11808, ORF19 ENSG00000175600 Succinyl-CoA:glutarate-CoA transferase 7 40134977-40860763 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026698, HPA026704, HPA026705 Supported Tissue enhanced 0 kidney: 44.6 liver: 14.6 SULT1C2 ST1C1, SULT1C1 ENSG00000198203 Sulfotransferase family, cytosolic, 1C, member 2 2 108288639-108309915 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007190 Approved Tissue enhanced 0 kidney: 68.6;stomach: 151.1 duodenum: 29.3 TCF24 bHLHa25 ENSG00000261787 Transcription factor 24 8 66946501-66962590 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence Tissue enhanced 0 kidney: 1.2;testis: 2.9 fallopian tube: 0.8 TFCP2L1 CRTR1, LBP-9 ENSG00000115112 Transcription factor CP2-like 1 2 121216587-121285207 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA029708 Uncertain Supported Nucleoli fibrillar center Tissue enhanced 0 kidney: 48.7 thyroid gland: 45.6 TLN2 ILWEQ, KIAA0320 ENSG00000171914 Talin 2 15 62390526-62844631 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017194 Approved Supported Focal adhesion sites
Cytosol Tissue enhanced 0 cerebral cortex: 41.0;kidney: 40.3 thyroid gland: 21.5 TMEM139 FLJ90586 ENSG00000178826 Transmembrane protein 139 7 143279957-143288048 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA036982, HPA036983 Approved Approved Plasma membrane
Focal adhesion sites Tissue enhanced 0 duodenum: 34.9;kidney: 34.4 small intestine: 21.2 TMEM252 C9orf71, MGC34760 ENSG00000181778 Transmembrane protein 252 9 68536580-68540867 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 kidney: 37.5;small intestine: 26.2 seminal vesicle: 15.4 TRABD2B TIKI2 ENSG00000269113 TraB domain containing 2B 1 47760528-47996895 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA045817 Approved Tissue enhanced 0 kidney: 7.7 seminal vesicle: 4.8 TRIM6 RNF89 ENSG00000121236 Tripartite motif containing 6 11 5596109-5612958 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA060514 Uncertain Tissue enhanced 0 kidney: 22.3 testis: 17.2 TRPM3 GON-2, KIAA1616, LTRPC3 ENSG00000083067 Transient receptor potential cation channel, subfamily M, member 3 9 70529063-71446904 Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 17.5 testis: 6.3 UGT2A3 FLJ21934 ENSG00000135220 UDP glucuronosyltransferase 2 family, polypeptide A3 4 68928463-68951791 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA045108 Supported Tissue enhanced 0 duodenum: 84.3;gallbladder: 46.5;kidney: 46.4;small intestine: 87.8 rectum: 24.3 UGT3A1 FLJ34658 ENSG00000145626 UDP glycosyltransferase 3 family, polypeptide A1 5 35951010-36001028 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA047697, HPA056290 Uncertain Approved Vesicles
Cytosol Tissue enhanced 0 kidney: 52.9;liver: 29.1 duodenum: 9.7 VAV3 ENSG00000134215 Vav 3 guanine nucleotide exchange factor 1 107571160-107965144 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002012 Uncertain Tissue enhanced 0 kidney: 90.1 skin: 58.8 VEPH1 FLJ12604, KIAA1692 ENSG00000197415 Ventricular zone expressed PH domain-containing 1 3 157259742-157533619 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA026645 Uncertain Approved Nucleus
Nucleoli
Cytosol Tissue enhanced 0 adrenal gland: 26.8;kidney: 28.5;lung: 43.9 epididymis: 21.0 WNK4 PRKWNK4 ENSG00000126562 WNK lysine deficient protein kinase 4 17 42780678-42796936 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016500 Approved Tissue enhanced 0 kidney: 18.9;prostate: 14.3;rectum: 12.1 colon: 8.9